Andrea Tedeschi
Overview
Explore the profile of Andrea Tedeschi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
2089
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gallucci G, Larocca M, Navazio A, Turazza F, Inno A, Canale M, et al.
Int J Mol Sci
. 2025 Jan;
26(1.
PMID: 39796190
The first part of this review highlighted the evolving landscape of atherosclerosis, noting emerging cardiometabolic risk factors, the growing impact of exposomes, and social determinants of health. The prominent role...
2.
Pugliatti P, Trimarchi G, Barocelli F, Pizzino F, Di Spigno F, Tedeschi A, et al.
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685743
Cardiac amyloidosis, encompassing both transthyretin (ATTR) and light-chain (AL) types, poses considerable challenges in patient management due to its intricate pathophysiology and progressive course. This narrative review elucidates the pivotal...
3.
Tedeschi A, Cusmano I, Di Salvo F, Oreni L, Toccafondi A, Tavanelli M, et al.
Int J Cardiol Cardiovasc Risk Prev
. 2024 Oct;
23:200345.
PMID: 39469252
Introduction: Heart transplantation (HTx) serves as the gold-standard therapy for end-stage heart failure, yet patients often experience physical deconditioning and cognitive impairments post-surgery. Cardiac rehabilitation (CR) has shown promise in...
4.
Quagliariello V, Canale M, Bisceglia I, Iovine M, Giordano V, Giacobbe I, et al.
Int J Mol Sci
. 2024 Oct;
25(20).
PMID: 39457081
Cancer patients, especially long cancer survivors, are exposed to several cardio-metabolic diseases, including diabetes, heart failure, and atherosclerosis, which increase their risk of cardiovascular mortality. Therapy with glucagon-like peptide 1...
5.
Canale M, Greco A, Inno A, Tedeschi A, De Biasio M, Oliva S, et al.
G Ital Cardiol (Rome)
. 2024 Sep;
25(10):711-719.
PMID: 39342555
Immunotherapy has revolutionized the treatment of various cancers leading to a clear survival benefit with cured or long-surviving patients. Atherosclerosis and cancer share risk factors and molecular mechanisms and have...
6.
Trimarchi G, Pizzino F, Paradossi U, Gueli I, Palazzini M, Gentile P, et al.
J Cardiovasc Dev Dis
. 2024 Aug;
11(8).
PMID: 39195153
Cardiovascular diseases (CVDs) remain a major global health challenge, leading to significant morbidity and mortality while straining healthcare systems. Despite progress in medical treatments for CVDs, their increasing prevalence calls...
7.
Lapi F, Marconi E, Casoli L, Tedeschi A, Giomi B, Cricelli C
Fam Pract
. 2024 Aug;
41(5):711-718.
PMID: 39181540
Background: Hidradenitis suppurativa (HS) is a persistent skin disorder that is characterized by painful lesions or pus-filled lumps, mostly occurring in areas where the skin flexes. It is a disfiguring...
8.
Tedeschi A, Ianni U, Gentile P, Palazzini M, Masciocco G, Ammirati E, et al.
Transplantation
. 2024 May;
108(6):e86-e87.
PMID: 38809433
No abstract available.
9.
Tedeschi A, Palazzini M, Trimarchi G, Conti N, Di Spigno F, Gentile P, et al.
J Clin Med
. 2024 May;
13(9).
PMID: 38731120
Heart failure (HF) is a leading cause of morbidity worldwide, imposing a significant burden on deaths, hospitalizations, and health costs. Anticipating patients' deterioration is a cornerstone of HF treatment: preventing...
10.
Roy D, Dion E, Sepeda J, Peng J, Lingam S, Townsend K, et al.
Cell Rep Med
. 2024 Apr;
5(5):101525.
PMID: 38663398
Spinal cord injury (SCI) increases the risk of cardiometabolic disorders, including hypertension, dyslipidemia, and insulin resistance. Not only does SCI lead to pathological expansion of adipose tissue, but it also...